157 related articles for article (PubMed ID: 18343835)
1. Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus.
Gabriel G; Nordmann A; Stein DA; Iversen PL; Klenk HD
J Gen Virol; 2008 Apr; 89(Pt 4):939-948. PubMed ID: 18343835
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers.
Lupfer C; Stein DA; Mourich DV; Tepper SE; Iversen PL; Pastey M
Arch Virol; 2008; 153(5):929-37. PubMed ID: 18369525
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers.
Stein DA
Curr Pharm Des; 2008; 14(25):2619-34. PubMed ID: 18991679
[TBL] [Abstract][Full Text] [Related]
4. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.
Deas TS; Bennett CJ; Jones SA; Tilgner M; Ren P; Behr MJ; Stein DA; Iversen PL; Kramer LD; Bernard KA; Shi PY
Antimicrob Agents Chemother; 2007 Jul; 51(7):2470-82. PubMed ID: 17485503
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers.
Paessler S; Rijnbrand R; Stein DA; Ni H; Yun NE; Dziuba N; Borisevich V; Seregin A; Ma Y; Blouch R; Iversen PL; Zacks MA
Virology; 2008 Jul; 376(2):357-70. PubMed ID: 18468653
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2.
Böttcher-Friebertshäuser E; Stein DA; Klenk HD; Garten W
J Virol; 2011 Feb; 85(4):1554-62. PubMed ID: 21123387
[TBL] [Abstract][Full Text] [Related]
7. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HSV-1 ocular infection with morpholino oligomers targeting ICP0 and ICP27.
Moerdyk-Schauwecker M; Stein DA; Eide K; Blouch RE; Bildfell R; Iversen P; Jin L
Antiviral Res; 2009 Nov; 84(2):131-41. PubMed ID: 19665486
[TBL] [Abstract][Full Text] [Related]
9. Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus.
Stein DA; Huang CY; Silengo S; Amantana A; Crumley S; Blouch RE; Iversen PL; Kinney RM
J Antimicrob Chemother; 2008 Sep; 62(3):555-65. PubMed ID: 18567576
[TBL] [Abstract][Full Text] [Related]
10. A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.
Stone JK; Rijnbrand R; Stein DA; Ma Y; Yang Y; Iversen PL; Andino R
Antimicrob Agents Chemother; 2008 Jun; 52(6):1970-81. PubMed ID: 18347107
[TBL] [Abstract][Full Text] [Related]
11. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
[TBL] [Abstract][Full Text] [Related]
12. An alternative strategy to increasing influenza virus replication for vaccine production in chicken embryo fibroblast (DF-1) cells by inhibiting interferon alpha and beta using peptide-conjugated phosphorodiamidate morpholino oligomers.
Prescott MA; Moulton H; Pastey MK
J Med Microbiol; 2024 Feb; 73(2):. PubMed ID: 38353513
[No Abstract] [Full Text] [Related]
13. Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.
Wang W; Li R; Deng Y; Lu N; Chen H; Meng X; Wang W; Wang X; Yan K; Qi X; Zhang X; Xin W; Lu Z; Li X; Bian T; Gao Y; Tan W; Ruan L
Clin Vaccine Immunol; 2015 Jun; 22(6):618-30. PubMed ID: 25834017
[TBL] [Abstract][Full Text] [Related]
14. The PB1 subunit alone can catalyze cRNA synthesis, and the PA subunit in addition to the PB1 subunit is required for viral RNA synthesis in replication of the influenza virus genome.
Nakagawa Y; Oda K; Nakada S
J Virol; 1996 Sep; 70(9):6390-4. PubMed ID: 8709268
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.
Rosenke K; Leventhal S; Moulton HM; Hatlevig S; Hawman D; Feldmann H; Stein DA
J Antimicrob Chemother; 2021 Jan; 76(2):413-417. PubMed ID: 33164048
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.
Ge Q; Pastey M; Kobasa D; Puthavathana P; Lupfer C; Bestwick RK; Iversen PL; Chen J; Stein DA
Antimicrob Agents Chemother; 2006 Nov; 50(11):3724-33. PubMed ID: 16966399
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.
Sleeman K; Stein DA; Tamin A; Reddish M; Iversen PL; Rota PA
Virus Res; 2009 Mar; 140(1-2):49-56. PubMed ID: 19059443
[TBL] [Abstract][Full Text] [Related]
19. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
[TBL] [Abstract][Full Text] [Related]
20. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
